Clinical trial
Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the…
NCT00413088 · Rovi Pharmaceuticals Laboratories, Industry · Completed
Key facts
| NCT number | NCT00413088 |
|---|---|
| Title | Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly |
| Official title | Clinical Trial to Assess Bemiparin Pharmacokinetics at Therapeutic (115 IU/kg) and Prophylactic Doses (3500 IU) Administered Subcutaneously in Single or Multiple Doses in Renal Insufficiency and in the Elderly |
| Lead sponsor | Rovi Pharmaceuticals Laboratories, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Renal Insufficiency |
| Intervention type | Drug |
| Interventions | bemiparin |
| Enrollment | 60 |
| Start date | Mar 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Dec 19, 2006 |
| Last update posted | Mar 18, 2011 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: